tiprankstipranks
Biosyent Inc (TSE:RX)
:RX
Canadian Market
RX
Biosyent
RESEARCH TOOLSreports
Want to see TSE:RX full AI Analyst Report?

Biosyent (RX) Ratios

53 Followers

Biosyent Ratios

TSE:RX's free cash flow for Q4 2025 was C$0.75. For the 2025 fiscal year, TSE:RX's free cash flow was decreased by C$ and operating cash flow was C$0.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.51 5.51 4.53 6.48 6.49
Quick Ratio
 4.63 4.63 3.54 5.42 5.70
Cash Ratio
 2.81 2.81 2.24 1.44 1.38
Solvency Ratio
 1.24 1.24 1.24 1.02 0.83
Operating Cash Flow Ratio
 1.29 1.33 1.60 0.91 0.87
Short-Term Operating Cash Flow Coverage
 43.57 44.88 44.06 0.00 0.00
Net Current Asset Value
C$ 31.82MC$ 31.82MC$ 18.11MC$ 29.10MC$ 30.02M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.03 0.03 0.03
Debt-to-Equity Ratio
 0.02 0.02 0.03 0.04 0.04
Debt-to-Capital Ratio
 0.02 0.02 0.03 0.03 0.04
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.19 1.19 1.18 1.19 1.21
Debt Service Coverage Ratio
 37.21 34.69 30.96 102.09 70.79
Interest Coverage Ratio
 230.13 229.23 147.98 109.21 90.51
Debt to Market Cap
 <0.01 <0.01 <0.01 0.00 0.00
Interest Debt Per Share
 0.08 0.08 0.09 0.11 0.12
Net Debt to EBITDA
 -1.52 -1.60 -1.06 -0.75 -0.87
Profitability Margins
Gross Profit Margin
76.04%74.59%79.52%81.03%81.85%
EBIT Margin
27.82%26.28%28.09%27.23%25.00%
EBITDA Margin
29.80%28.26%29.78%28.67%26.62%
Operating Profit Margin
26.38%26.28%24.99%23.65%25.00%
Pretax Profit Margin
27.94%27.94%27.93%27.01%26.61%
Net Profit Margin
20.93%20.93%20.75%20.45%19.55%
Continuous Operations Profit Margin
20.93%20.93%20.75%20.45%19.55%
Net Income Per EBT
74.91%74.91%74.32%75.70%73.46%
EBT Per EBIT
105.92%106.34%111.76%114.22%106.43%
Return on Assets (ROA)
18.23%18.23%17.58%15.56%13.48%
Return on Equity (ROE)
23.26%21.73%20.77%18.59%16.36%
Return on Capital Employed (ROCE)
26.90%26.79%24.34%20.76%20.08%
Return on Invested Capital (ROIC)
20.05%19.97%17.90%15.63%14.68%
Return on Tangible Assets
20.19%20.19%20.02%16.00%13.89%
Earnings Yield
5.59%6.29%5.70%6.04%6.34%
Efficiency Ratios
Receivables Turnover
 9.49 9.49 11.70 8.91 7.64
Payables Turnover
 1.68 1.78 1.79 1.18 1.00
Inventory Turnover
 1.61 1.71 1.35 1.02 1.12
Fixed Asset Turnover
 43.81 43.81 29.17 21.94 16.69
Asset Turnover
 0.87 0.87 0.85 0.76 0.69
Working Capital Turnover Ratio
 1.40 1.67 1.42 1.02 0.91
Cash Conversion Cycle
 47.96 47.42 98.82 90.73 9.80
Days of Sales Outstanding
 38.46 38.46 31.20 40.98 47.80
Days of Inventory Outstanding
 227.03 214.04 271.05 359.04 326.68
Days of Payables Outstanding
 217.54 205.09 203.44 309.29 364.68
Operating Cycle
 265.50 252.51 302.25 400.02 374.48
Cash Flow Ratios
Operating Cash Flow Per Share
 0.83 0.85 0.75 0.42 0.40
Free Cash Flow Per Share
 0.79 0.85 0.34 0.41 0.36
CapEx Per Share
 0.03 <0.01 0.40 0.01 0.04
Free Cash Flow to Operating Cash Flow
 0.96 0.99 0.46 0.97 0.90
Dividend Paid and CapEx Coverage Ratio
 3.54 4.17 1.28 2.42 4.93
Capital Expenditure Coverage Ratio
 24.19 177.99 1.86 29.01 9.53
Operating Cash Flow Coverage Ratio
 11.10 11.44 8.35 4.14 3.55
Operating Cash Flow to Sales Ratio
 0.22 0.22 0.25 0.16 0.18
Free Cash Flow Yield
5.44%6.67%3.13%4.56%5.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 17.88 15.91 17.53 16.56 15.78
Price-to-Sales (P/S) Ratio
 3.82 3.33 3.64 3.39 3.08
Price-to-Book (P/B) Ratio
 3.89 3.46 3.64 3.08 2.58
Price-to-Free Cash Flow (P/FCF) Ratio
 18.38 14.99 31.91 21.91 19.44
Price-to-Operating Cash Flow Ratio
 17.26 14.90 14.71 21.16 17.40
Price-to-Earnings Growth (PEG) Ratio
 0.63 0.59 1.05 0.73 -1.31
Price-to-Fair Value
 3.89 3.46 3.64 3.08 2.58
Enterprise Value Multiple
 11.31 10.19 11.16 11.06 10.72
Enterprise Value
 145.08M 123.92M 116.38M 100.19M 79.65M
EV to EBITDA
 11.31 10.19 11.16 11.06 10.72
EV to Sales
 3.37 2.88 3.32 3.17 2.85
EV to Free Cash Flow
 16.20 12.95 29.14 20.53 17.98
EV to Operating Cash Flow
 15.53 12.88 13.43 19.82 16.10
Tangible Book Value Per Share
 3.26 3.26 2.59 2.81 2.61
Shareholders’ Equity Per Share
 3.68 3.68 3.02 2.91 2.71
Tax and Other Ratios
Effective Tax Rate
 0.25 0.25 0.26 0.24 0.27
Revenue Per Share
 3.82 3.82 3.02 2.64 2.27
Net Income Per Share
 0.80 0.80 0.63 0.54 0.44
Tax Burden
 0.75 0.75 0.74 0.76 0.73
Interest Burden
 1.00 1.06 0.99 0.99 1.06
Research & Development to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
 0.46 0.48 0.50 0.31 0.32
Stock-Based Compensation to Revenue
 0.01 0.00 0.02 0.02 0.02
Income Quality
 1.04 1.07 1.19 0.78 0.91
Currency in CAD